Description
PHARMACEUTICAL PURCHASE OF SOLARIS
First action · last action
2013-06-11 · 2013-08-29
Transactions
4
First transaction's obligation
$25,261
Base + all options value (sum of deltas)
$101,044
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D30015
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-06-11+$25,261= $25,261
- Mod P000012013-07-09+$25,261= $50,522
- Mod P000022013-08-09+$25,261= $75,783
- Mod P000032013-08-29+$25,261= $101,044
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-06-11 | +$25,261 | $25,261 | PHARMACEUTICAL PURCHASE OF SOLARIS |
| Mod P00001· EXERCISE AN OPTION | 2013-07-09 | +$25,261 | $50,522 | PHARMACEUTICAL PURCHASE OF SOLARIS |
| Mod P00002· EXERCISE AN OPTION | 2013-08-09 | +$25,261 | $75,783 | PHARMACEUTICAL PURCHASE OF SOLARIS |
| Mod P00003· EXERCISE AN OPTION | 2013-08-29 | +$25,261 | $101,044 | PHARMACEUTICAL PURCHASE OF SOLARIS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI DKCXLGANZAN3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79726A0021 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C24526N0739 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $104,650 | FY2026 |
| 36F79726D0143 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C26026F0055 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $1,255,805 | FY2026 |
| 36C26025F0093 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $626,866 | FY2025 |
| 36C26024F0096 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $522,487 | FY2024 |
Other recipients under 6505 from 258-NETWORK CONTRACT OFFICE 18 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25816P1062 | MCKESSON CORPORATION | 258-NETWORK CONTRACT OFFICE 18 | $18,604 | FY2016 |
| VA25816E1145 | MCKESSON CORPORATION | 258-NETWORK CONTRACT OFFICE 18 | $10,361,853 | FY2016 |
| VA25816P0866 | MCKESSON CORPORATION | 258-NETWORK CONTRACT OFFICE 18 | $27,127 | FY2016 |
| VA25816J0835 | MDD US OPERATIONS, LLC | 258-NETWORK CONTRACT OFFICE 18 | $3,524 | FY2016 |
| VA25816E1024 | MCKESSON CORPORATION | 258-NETWORK CONTRACT OFFICE 18 | $9,829,900 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25813J1426_3600_V797D30015_3600 · retrieved 2026-09-26.